Soleno Therapeutics, Inc.
SLNO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,805,908 | $663,808 | $83,131 | $163,529 |
| - Cash | $87,928 | $169,681 | $14,602 | $21,304 |
| + Debt | $52,826 | $403 | $155 | $457 |
| Enterprise Value | $1,770,806 | $494,530 | $68,684 | $142,682 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$173,632 | -$37,030 | -$22,103 | -$30,296 |
| % Margin | – | – | – | – |
| Net Income | -$175,850 | -$38,988 | -$24,067 | -$30,910 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.38 | -2.36 | -2.87 | -5.81 |
| % Growth | -85.6% | 17.8% | 50.6% | – |
| Operating Cash Flow | -$69,096 | -$24,940 | -$20,781 | -$27,770 |
| Capital Expenditures | -$218 | $0 | -$13 | -$22 |
| Free Cash Flow | -$69,314 | -$24,940 | -$20,794 | -$27,792 |